Nanotechnology drug delivery shows promise for treatment of pediat... ( Wilmington DE This month Molecular...)

Nanotechnology drug delivery shows promise for treatment of pediatric cancer

Date:12/4/2012

Wilmington, DE This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for nanotechnology to deliver chemotherapeutic agents in a way that attacks cancer cells without harming healthy cells. To date, nanoparticle-based drug delivery approaches have been poorly developed for the treatment of childhood leukemia, which comprises 30% of childhood cancers. In the Nemours study, encapsulated dexamethasone ("dex") delivered to pre-clinical models with leukemia significantly improved quality of life and survival compared to the control receiving the unencapsulated drug.

Acute lymphoblastic leukemia (ALL) is the most common form of pediatric leukemia. Although 5-year survival rates for ALL approach 90% with available chemotherapy treatments, the deleterious side effects of the drugs, including secondary cancers and fertility, cognitive, hearing, and developmental problems, present a significant concern for survivors and their families. Dex is one of the most commonly used drugs to treat childhood leukemia and long-term systemic exposure to dex causes considerable side effects.

Studies conducted by the lead author A. K. Rajasekaran, PhD, and his team at Nemours in collaboration with Xinqiao Jia, PhD, and her team at the University of Delaware, used polymeric nanoparticles containing chemotherapeutic agents to ensure controlled delivery of drugs to cancer cells in preclinical models. "There are currently seven or eight drugs that are used for chemotherapy to treat leukemia in children," said Dr. Rajasekaran. "They are all toxic and do their job by killing rapidly dividing cells." However, he explained, these drugs don't differentiate cancer cells from other, healthy cells. "The good news is that these drugs are 80-90% effective in curing leukemia. The bad news is that many chemot
'/>"/>

Contact: Karen Bengston
kbengsto@nemours.org
302-298-7319
Nemours
Source:Eurekalert

0

GOOD

Page: 1 2
Related biology news :

1. Purdue professor to speak before Congress about nanotechnology in brain treatment research
2. New study shows how nanotechnology can help detect disease earlier
3. Nanotechnology breakthrough could dramatically improve medical tests
4. Understanding the biological and ecological implications of safe nanotechnology
5. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
6. Realizing the promise of RNA nanotechnology for new drug development
7. Mercury in water, fish detected with nanotechnology
8. European boost for DNA nanotechnology
9. Global Market for Nanotechnology to Reach $3.3 Trillion by 2018
10. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
11. Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial

Post Your Comments:

(Date:6/19/2013)... provider of scientific, technical and medical information products and ... new open access journal, GeoResJ . , ... and planetary science journals portfolio has its first open ... forum for rapid publication of top research within the ... by six Executive Editors, each covering a different discipline, ...

(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...

(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...

Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2 NIH to fund collaborations with industry to identify new uses for existing compounds 2 NIH to fund collaborations with industry to identify new uses for existing compounds 3 NIH to fund collaborations with industry to identify new uses for existing compounds 4

[0] Elsevier launches open access journal: GeoResJ [0] UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline [0] NIH to fund collaborations with industry to identify new uses for existing compounds

... A Century of Change, literally took 100 years to write. ... from 1906-1909. It was repeated from 1956-1958 and a technical ... anniversary of that first survey was approaching, ornithologists Mike Ward, ... of opportunity to do it again and write a book, ...

... the United States and Japan analyzed fossil evidence found ... horned dinosaur. The newly identified genus, Koreaceratops ... the late Early Cretaceous period. The specimen is ... The partial skeleton includes a significant portion of the ...

... social stress activates the immune system and accelerates the ... pressure, however, may stop this process. This is the ... Gothenburg, Sweden. Several large studies have clearly shown ... the risk of developing cardiovascular disease. However, little is ...

Cached Biology News:New book on 100 years of Illinois birds 2 New book on 100 years of Illinois birds 3 New book on 100 years of Illinois birds 4 Scientists announce discovery of first horned dinosaur from South Korea 2 Social stress leads to atherosclerosis 2

New book on 100 years of Illinois birds Scientists announce discovery of first horned dinosaur from South Korea Social stress leads to atherosclerosis

(Date:6/19/2013)... , June 19, 2013 Biotechnology industry pioneer ... up with financial software provider BlackLine Systems and ... SAP ) for a webinar next week entitled ... Solutions from BlackLine and SAP to Help Keep Its Account ... http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared at ...

(Date:6/19/2013)... A new look at “big glass” and ... will highlight technical sessions at SPIE Photomask Technology ... 33rd year, the three-day event is the industry’s largest ... approximately 100 technical presentations and numerous networking lunches and ... optics and photonics , the meeting will be held ...

(Date:6/18/2013)... HONG KONG, June 18, 2013 China Cord ... the "Company"), China,s leading provider of cord blood collection, ... storage services, today announced its preliminary unaudited financial results ... year 2013 ended March 31, 2013. ... for the fourth quarter of fiscal 2013 increased by ...

(Date:6/18/2013)... 18, 2013 The human skin is the ... an important human body part. Similar to the liver, or ... to function, repair and grow. Recent reports from the mankatofreepress.com ... is just as important as other life supporting organs. The ... in skin cell reproduction, increase the appearance of skin, and ...

[0] Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations [0] ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin

... Jan. 4, 2011 Advanced Life Sciences Holdings, ... a biopharmaceutical company engaged in the discovery, development and ... infection, oncology and respiratory diseases, today announced that it ... Conference held January 10-12th in San Francisco. ...

... a biological weapon so specific, it can target an individual ... seeds of death are sown into the very blueprints of ... of us, buried deep within the human genetic code. How ... diseases? Doug Flanders ponders these very questions in ...

... Jan. 4, 2011 Reportlinker.com announces ... is available in its catalogue: ... Market: DNA Probes and Biochips New ... Strategies for Instrument and Reagent Suppliers ...

Cached Biology Technology:Advanced Life Sciences to Present at the Biotech Showcase™ 2011 Conference 2 James Bond Meets Cheaper by the Dozen: An Action Thriller the Entire Family Will Enjoy 2 Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers 2

Advanced Life Sciences to Present at the Biotech Showcase™ 2011 Conference James Bond Meets Cheaper by the Dozen: An Action Thriller the Entire Family Will Enjoy Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

...

UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity....

...

Water Distilled (Gibco™) is membrane filtered and endotoxin screened....

Biology Products:

Polyvalent HRP AEC Detection System from Spring Bioscience UltraPure DNase/RNase-Free Distilled Water from Invitrogen Luminex 100 IS System from Luminex Corporation GIBCO Water distilled from Invitrogen